Clinical Chemistry Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 54: 927-928, 2008; 10.1373/clinchem.2007.099770
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zouwail, S. A.
Right arrow Articles by Begley, J. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zouwail, S. A.
Right arrow Articles by Begley, J. P.
(Clinical Chemistry. 2008;54:927-928.)
© 2008 American Association for Clinical Chemistry, Inc.

Letters to the Editor

Influence of Thyroid Hormone Autoantibodies on 7 Thyroid Hormone Assays

Soha A. Zouwail1,a, Angela M. O’Toole2, Penelope M. S. Clark2 and Joe P. Begley1,3

1 Department of Clinical Biochemistry, Poole and Royal Bournemouth Hospitals, Dorset, UK
2 Regional Endocrine Laboratory, University Hospital Birmingham, NHS Foundation Trust, Birmingham, UK
3 Centre of Postgraduate Medical Research and Education, Bournemouth University, Dorset, UK

aAddress correspondence to this author at: Poole Hospital, Longfleet Road, Poole, Dorset, UK, BH15 2JB, Fax +44-1202-448454, e-mail soha.zouwail@poole.nhs.uk

The first 20% of the full text of this article appears below.


To the Editor:

Spurious results of thyroid function tests (TFT) can be recognized when they do not reflect the clinical status of the patient or are not internally consistent [e.g., increased FT4 with nonsuppressed thyroid-stimulating hormone (TSH)]. Potential causes of spurious TFT results include nonspecific binding of endogenous circulating factors, such as heterophilic antibodies, with assay reagents(1), the presence of albumin variants found in familial dysalbuminemic hyperthyroxinaemia(2), and thyroid hormone autoantibodies (THAA)(3). We describe a patient who had discordant TFTs due to circulating THAA and report differences in TFT results obtained on a variety of automated immunoassay platforms.

A 19-year-old man presented with tiredness spanning a 12-month period following a prolonged viral illness. A family history of hypothyroidism prompted a request for TFTs. These showed increased FT4 of 60 pmol/L (reference interval 10–25 pmol/L) and FT3 of 8.1 pmol/L (reference interval 2.5–6.5 pmol/L), but an nonsuppressed TSH of 0.9 mU/L (reference interval 0.3–5.5 mU/L). The tests were . . . [Full Text of this Article]






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by the American Association for Clinical Chemistry.